Recombinant hepatitis E vaccine

  • FOB Price:Get Latest Price >
  • Min.Order:100 Box(es)
  • Payment Terms:L/C,T/T,D/P,PayPal,Western Union,Small-amount payment,Money Gram,
  • Favorite
Xiamen Innovax Biotech Co., Ltd.

Business Type:Manufacturer

Total Employees:Unselected

Location:China

Licenses Verified

Verified Supplier

HOT Rank

8/10

Product Information

  • Dosage Form:Injection
  • Route of Administration:Intramuscular Injection
  • Shelf Life:3 years
  • Storage:2℃-8℃

Description

[Quality standard] Company Standard (YBS01402011)

[Suitable population] This product is suitable for susceptible population aged 16 and above. It is recommended for individuals exposed to high risk of hepatitis E virus infection, such as those engaged in animal husbandry and catering, students, officers and soldiers, women of childbearing age, travelers to endemic areas and so on.

[Specification] 30µg/0.5ml/dose

[Route of Administration] 3 doses of intramuscular injection following the 0, 1 months, 6 months schedule, that is the first dose on the first day, the second dose one month after the first injection,and the third dose six months after the first injection.

[Shelf life] 2-8℃ for 36 months

[Highlights]

•Launched in Oct. 2012, China

•The world's first vaccine against hepatitis E

•Up to 4.5 years, the long-term efficacy against clinical HE was 93.3% (78.6-97.9) and 86.8% (71.0-94.0) in per-protocol and intention-to-treat analysis, respectively.

•Complete phase I, II, III, IV Clinical Trial conducted in China


Inquiry Cart(0)